财经频道更多独家策划、专家专栏，免费查阅>>责任编辑：钟离 格隆汇10月24日丨莎普爱思(603168.SH)公布，公司收到国家药品监督管理局核发的盐酸奥布卡因滴眼 液的《药品注册证书》（证书编号：2025S03202），本次获批的盐酸奥布卡因滴眼液，可用于眼科领 域内的表面麻醉。 ...

格隆汇10月24日丨莎普爱思(603168.SH)公布，公司收到国家药品监督管理局核发的盐酸奥布卡因滴眼 液的《药品注册证书》（证书编号：2025S03202），本次获批的盐酸奥布卡因滴眼液，可用于眼科领 域内的表面麻醉。 ...

Core Viewpoint - The company received the drug registration certificate for Oubkain Hydrochloride Eye Drops from the National Medical Products Administration, indicating a significant regulatory approval for a product used in ophthalmic surface anesthesia [1] Company Summary - Shapais (603168) announced on October 24 that it has obtained the drug registration certificate for Oubkain Hydrochloride Eye Drops [1] - The eye drops are intended for use in the field of ophthalmology, specifically for surface anesthesia [1]